Literature DB >> 8389717

Molecular cloning of a human beta 3-adrenergic receptor cDNA.

J M Lelias1, M Kaghad, M Rodriguez, P Chalon, J Bonnin, I Dupre, B Delpech, M Bensaid, G LeFur, P Ferrara.   

Abstract

We report the molecular cloning of a beta 3-adrenergic receptor [beta 3-AR] cDNA from human brown adipose tissue. The cDNA-encoded protein is identical to the previously cloned beta 3-AR but with 6 additional amino acids at the C-terminus. The C-terminus is shared by the beta 3 receptors expressed in human neuroblastoma cells [SK-N-MC] [Mol. Pharmacol. 42 (1992) 964-970]. Furthermore, using a polymerase chain reaction strategy we have cloned and sequenced the beta 3-AR introns. Sequence analysis demonstrates that the human beta 3-AR gene comprises at least 3 exons and 2 introns and that the most abundant beta 3-AR transcripts encode a protein with an exon 3-derived C-terminus. Interestingly, although a similar organization has been found in rodent genes, the rat beta 3-AR transcripts encode a receptor with an exon 2-derived C-terminus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389717     DOI: 10.1016/0014-5793(93)81377-c

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Insights into the binding modes of human β₃-adrenergic receptor agonists with ligand-based and receptor-based methods.

Authors:  Fangfang Jin; Chunhua Lu; Xianqiang Sun; Weihua Li; Guixia Liu; Yun Tang
Journal:  Mol Divers       Date:  2011-03-20       Impact factor: 2.943

2.  The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects cohorts.

Authors:  J Gagnon; P Mauriège; S Roy; D Sjöström; Y C Chagnon; F T Dionne; J M Oppert; L Pérusse; L Sjöström; C Bouchard
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 3.  Agonist-induced desensitisation of β3 -adrenoceptors: Where, when, and how?

Authors:  Katerina Okeke; Stephane Angers; Michel Bouvier; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

4.  β(3) Receptors: Role in Cardiometabolic Disorders.

Authors:  Shraddha V Bhadada; Bhoomika M Patel; Anita A Mehta; Ramesh K Goyal
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

Review 5.  Tools to study beta3-adrenoceptors.

Authors:  Wim Vrydag; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-09       Impact factor: 3.000

6.  Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins.

Authors:  L Manara; D Badone; M Baroni; G Boccardi; R Cecchi; T Croci; A Giudice; U Guzzi; M Landi; G Le Fur
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.

Authors:  N Blin; C Nahmias; M F Drumare; A D Strosberg
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

8.  Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer.

Authors:  X E Huang; N Hamajima; T Saito; K Matsuo; M Mizutani; H Iwata; T Iwase; S Miura; T Mizuno; S Tokudome; K Tajima
Journal:  Breast Cancer Res       Date:  2001-04-26       Impact factor: 6.466

Review 9.  Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity.

Authors:  Xiao-Rong Peng; Peter Gennemark; Gavin O'Mahony; Stefano Bartesaghi
Journal:  Front Endocrinol (Lausanne)       Date:  2015-11-19       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.